308 related articles for article (PubMed ID: 25398795)
1. Tolerated doses in zebrafish of cytochalasins and jasplakinolide for comparison with tolerated doses in mice in the evaluation of pre-clinical activity of microfilament-directed agents in tumor model systems in vivo.
Trendowski M; Wong V; Wellington K; Hatfield S; Fondy TP
In Vivo; 2014; 28(6):1021-31. PubMed ID: 25398795
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models.
Trendowski M; Mitchell JM; Corsette CM; Acquafondata C; Fondy TP
Invest New Drugs; 2015 Apr; 33(2):290-9. PubMed ID: 25563824
[TBL] [Abstract][Full Text] [Related]
3. Enlargement and multinucleation of u937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents.
Trendowski M; Wong V; Yu G; Fondy TP
Anticancer Res; 2015 Jan; 35(1):65-76. PubMed ID: 25550536
[TBL] [Abstract][Full Text] [Related]
4. Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro.
Trendowski M; Christen TD; Acquafondata C; Fondy TP
BMC Cancer; 2015 Sep; 15():632. PubMed ID: 26357852
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration.
Trendowski M; Mitchell JM; Corsette CM; Acquafondata C; Fondy TP
Invest New Drugs; 2015 Apr; 33(2):280-9. PubMed ID: 25560541
[TBL] [Abstract][Full Text] [Related]
6. Preferential enlargement of leukemia cells using cytoskeletal-directed agents and cell cycle growth control parameters to induce sensitivity to low frequency ultrasound.
Trendowski M; Wong V; Zoino JN; Christen TD; Gadeberg L; Sansky M; Fondy TP
Cancer Lett; 2015 May; 360(2):160-70. PubMed ID: 25667120
[TBL] [Abstract][Full Text] [Related]
7. Differential interactions of cytochalasins with P-glycoprotein.
Zilfou JT; Smith CD
Oncol Res; 1995; 7(9):435-43. PubMed ID: 8835287
[TBL] [Abstract][Full Text] [Related]
8. Latrunculins--novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D.
Spector I; Shochet NR; Blasberger D; Kashman Y
Cell Motil Cytoskeleton; 1989; 13(3):127-44. PubMed ID: 2776221
[TBL] [Abstract][Full Text] [Related]
9. Evidence that actin depolymerization protects hippocampal neurons against excitotoxicity by stabilizing [Ca2+]i.
Furukawa K; Smith-Swintosky VL; Mattson MP
Exp Neurol; 1995 Jun; 133(2):153-63. PubMed ID: 7649222
[TBL] [Abstract][Full Text] [Related]
10. Exploiting the cytoskeletal filaments of neoplastic cells to potentiate a novel therapeutic approach.
Trendowski M
Biochim Biophys Acta; 2014 Dec; 1846(2):599-616. PubMed ID: 25286320
[TBL] [Abstract][Full Text] [Related]
11. Effects of multidrug resistance-related ATP-binding-cassette transporter proteins on the cytoskeletal activity of cytochalasins.
Berger W; Micksche M; Elbling L
Exp Cell Res; 1997 Dec; 237(2):307-17. PubMed ID: 9434626
[TBL] [Abstract][Full Text] [Related]
12. Effects of small doses of cytochalasins on fibroblasts: preferential changes of active edges and focal contacts.
Domnina LV; Gelfand VI; Ivanova OY; Leonova EV; Pletjushkina OY; Vasiliev JM; Gelfand IM
Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7754-7. PubMed ID: 6961447
[TBL] [Abstract][Full Text] [Related]
13. In vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells.
Van Goietsenoven G; Mathieu V; Andolfi A; Cimmino A; Lefranc F; Kiss R; Evidente A
Planta Med; 2011 May; 77(7):711-7. PubMed ID: 21058241
[TBL] [Abstract][Full Text] [Related]
14. Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin in vitro.
Yahara I; Harada F; Sekita S; Yoshihira K; Natori S
J Cell Biol; 1982 Jan; 92(1):69-78. PubMed ID: 7199054
[TBL] [Abstract][Full Text] [Related]
15. Effect of cytochalasins on surfactant release from alveolar type II cells.
Rice WR; Osterhoudt KC; Whitsett JA
Biochim Biophys Acta; 1984 Sep; 805(1):12-8. PubMed ID: 6541060
[TBL] [Abstract][Full Text] [Related]
16. Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma.
Bousquet PF; Paulsen LA; Fondy C; Lipski KM; Loucy KJ; Fondy TP
Cancer Res; 1990 Mar; 50(5):1431-9. PubMed ID: 2302708
[TBL] [Abstract][Full Text] [Related]
17. New cytochalasins from medicinal macrofungus Crodyceps taii and their inhibitory activities against human cancer cells.
Li XG; Pan WD; Lou HY; Liu RM; Xiao JH; Zhong JJ
Bioorg Med Chem Lett; 2015 May; 25(9):1823-6. PubMed ID: 25863432
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer.
Marshall JL; Wellstein A; Rae J; DeLap RJ; Phipps K; Hanfelt J; Yunmbam MK; Sun JX; Duchin KL; Hawkins MJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2347-54. PubMed ID: 9815633
[TBL] [Abstract][Full Text] [Related]
19. Variation in the activity of distinct cytochalasins as autophagy inhibitiors in human lung A549 cells.
Takanezawa Y; Nakamura R; Sone Y; Uraguchi S; Kobayashi K; Tomoda H; Kiyono M
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):641-647. PubMed ID: 29106958
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic cytochalasins from the endozoic fungus Phoma sp. of the giant jellyfish Nemopilema nomurai.
Kim EL; Li JL; Dang HT; Hong J; Lee CO; Kim DK; Yoon WD; Kim E; Liu Y; Jung JH
Bioorg Med Chem Lett; 2012 May; 22(9):3126-9. PubMed ID: 22483395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
